With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|The Cebpa Downstream Enhancer as a Key Target of Transformation to Acute Myeloid Leukemia||The Johns Hopkins University School of Medicine / Stacy Cooper, MD||Young Investigator Grants||2015||Maryland|
|The Role of PARP3 in the Formation of Chromosomal Translocations||Dana-Farber Cancer Institute / Tovah Day, PhD||Young Investigator Grants||2015||Massachusetts|
|The Regulation of Hematopoietic Stem Cell Function by Granulocyte-Colony Stimulating Factor||Washington University / Laura Schuettpelz, MD, PhD||Young Investigator Grants||2013||Missouri|
|Dissecting and Targeting the Wnt Signaling Pathway in Metastatic Osteosarcoma||Baylor College of Medicine / Jason T. Yustein, MD, PhD||Young Investigator Grants||2013||Texas|
|PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia||Massachusetts General Hospital / Jessica Blackburn, PhD||Young Investigator Grants||2013||Massachusetts|
|Research Institute at Nationwide Children's Hospital / Mary Beth Ross, MD/PhD||Young Investigator Grants||2006||Ohio|
|Epigenetic Regulation of T cell Activation and Immunotherapy||The Johns Hopkins University School of Medicine / Brian Ladle, MD, PhD||Young Investigator Grants||2013||Maryland|
|Oncogenic Hedgehog Pathway Activation by a Putative Rho GTPase-Activating Protein||Lucile Packard Children's Hospital at Stanford University School of Medicine / Jun Ni, PhD||Young Investigator Grants||2013||California|
|Histone Modification and Hmgn1 Overexpression as Drivers of B-ALL with Polysomy 21||Dana-Farber Cancer Institute / Andrew Lane, MD, PhD||Young Investigator Grants||2013||Massachusetts|
|The Role of PTPRD as a Tumor Suppressor in Neuroblastoma Pathogenesis||Mayo Clinic / Shizhen Zhu, MD, PhD||Young Investigator Grants||2013||Minnesota|